These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 10837440

  • 21. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
    Block SL, Cifaldi M, Gu Y, Paris MM.
    Clin Ther; 2005 Jun; 27(6):786-94. PubMed ID: 16117986
    [Abstract] [Full Text] [Related]

  • 22. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 23. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
    Klietmann W, Cesana M, Rondel RK, Focht J.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2298-306. PubMed ID: 8285609
    [Abstract] [Full Text] [Related]

  • 24. Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
    McCarty JM, Pierce PF.
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):327-34. PubMed ID: 11686426
    [Abstract] [Full Text] [Related]

  • 25. Pediatric tonsillopharyngitis--an evaluation of cefprozil in Indian patients.
    Gupta N, Mukherjee A, Moharana AK.
    Indian J Pediatr; 2004 Jul; 71(7):601-5. PubMed ID: 15280609
    [Abstract] [Full Text] [Related]

  • 26. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
    Leigh AP, Nemeth MA, Keyserling CH, Hotary LH, Tack KJ.
    Clin Ther; 2000 Jul; 22(7):818-25. PubMed ID: 10945508
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
    Ball P.
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):851-6. PubMed ID: 7889959
    [Abstract] [Full Text] [Related]

  • 28. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC, Kapral D, Busman TA, Paris MM.
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [Abstract] [Full Text] [Related]

  • 29. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Cranfield R, Breisch S, Pettit R.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
    [Abstract] [Full Text] [Related]

  • 30. Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis.
    Vogel F, Droszcz W, Vondra V, Reisenberg K, Marr C, Staley H.
    J Antimicrob Chemother; 1997 Dec; 40(6):863-71. PubMed ID: 9462439
    [Abstract] [Full Text] [Related]

  • 31. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
    Wilson R, Schentag JJ, Ball P, Mandell L, 068 Study Group.
    Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
    [Abstract] [Full Text] [Related]

  • 32. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.
    O'Doherty B, Daniel R.
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290
    [Abstract] [Full Text] [Related]

  • 33. Redefining the management of pediatric tonsillopharyngitis with cefprozil.
    Jerath N, Shetty G.
    Indian J Pediatr; 2007 Dec; 74(12):1105-8. PubMed ID: 18174646
    [Abstract] [Full Text] [Related]

  • 34. Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir.
    Brook I, Gober AE.
    Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):757-9. PubMed ID: 19285734
    [Abstract] [Full Text] [Related]

  • 35. Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
    Pelletier LL.
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S238-43; discussion S244-5. PubMed ID: 1617044
    [Abstract] [Full Text] [Related]

  • 36. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
    Wasilewski MM, Johns D, Sides GD.
    J Antimicrob Chemother; 1999 Apr; 43(4):541-8. PubMed ID: 10350384
    [Abstract] [Full Text] [Related]

  • 37. Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity.
    Davies BI, Maesen FP.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():83-90. PubMed ID: 10404344
    [Abstract] [Full Text] [Related]

  • 38. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
    Gotfried MH, Ellison WT.
    Am J Med; 1992 Apr 06; 92(4A):108S-113S. PubMed ID: 1316059
    [Abstract] [Full Text] [Related]

  • 39. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
    Shah PM, Maesen FP, Dolmann A, Vetter N, Fiss E, Wesch R.
    J Antimicrob Chemother; 1999 Apr 06; 43(4):529-39. PubMed ID: 10350383
    [Abstract] [Full Text] [Related]

  • 40. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML, Jacobson KD, Guerra FJ, Therasse DG, Farlow D.
    Clin Ther; 1992 Apr 06; 14(2):214-29. PubMed ID: 1611645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.